Brachytherapy: pushing the limits of ablative therapy | Virtual Conference

At the end of this activity, the participant will be able to 

• Summarize the review of literature
• Indentify the indications and benefits of vaginal brachytherapy
• Discuss the outcomes of this treatment

At the end of this activity, the participant will be able to

• Identify the indications and benefits of image guidance
• Master needle placement in interstitial brachytherapy
• Explain adaptive treatment
• Recognize GEC-ESTRO recommendations

At the end of this activity, the participant will be able to

• Identify the need for endocavitary and insterstitial brachytherapy
• Recognize hard to reach areas
• Explain needle placement (steering) in difficult areas
• Discuss the different dose and fractionation schemes

Simultaneous closed sessions for a maximum of 10 pariticpants. Each workshop lasts 30 minutes.

.

At the end of this activity, the participant will be able to explain the basic principles of automatic dose optimization.

At the end of this activity, the participant will be able to explain the different algorithms used.

At the end of this activity, the participant will be able to illustrate the use of inverse planning brachytherapy for different tumoral sites.

At the end of this activity, the participant will be able to identify the optimal use and advantages on inverse planning in brachytherapy.

At the conclusion of this activity, the participant will be able to explain the need for manual adjustments to an inversely optimized plan.

At the conclusion of this activity, the participant will be able to identify the possible use of AI in inverse planning. 

At the conclusion of this activity, the participant will be able to explain the principles of automation and inverse planning.

At the conclusion of this activity, the participant will be able to explain the dosimetric criteria used in the HDR boost. p

At the conclusion of this activity, the participant will be able to discuss the dosimetric compromised and solution space related to HDR prostate

At the end of this activity, the participant will be able to

• Summarize the review of the literature
• Discuss the technical aspects of this procedure
• Explain the indications of this procedure
• Discuss the outcomes of this procedure

At the end of this activity, the participant will be able to

• Discuss the technical aspects of this procedure
• Recognize the indications for hepatocarcinomas
• Recognize the indications for metastases
• Compare a brachytherapy dosimetry to SBRT dosimetry
• Discuss the outcomes of this procedure

At the end of this activity, the participant will be able to

• Summarize the review of the litterature
• Discuss the different published doses, and their prescription
• Discuss the outcomes of this treatment

At the end of this activity, the participant will be able to

• Summarize the variability of the different monotherapy regimens
• Describe normal tissue reaction
• Explain the radiobiological basis for the single fraction failure rate

At the end of this activity, the participant will be able to

• Determine the risk and incidence of urethral structures
• Explain the predictive value of the prescription dose as well as the dose to OARs
• Explain the predictive value of implant technique
• Analyse the dosimetric implications 

At the end of this activity, the participant will be able to

• Summarize the literature available
• Compare results with whole gland treatment
• Discuss the use of multi modality imaging:  MRI, PET-PSMA

At the end of this activity, the participant will be able to

• Summarize the litterature
• Discuss its indications, and the different fractionations used
• Discuss the toxicities of this treatment

At the end of this activity, the participant will be able to- Review of the litterature

• Recognize the indications for penile brachytherapy
• Discuss the technical aspects of this procedure
• Discuss the outcomes of this procedure